The Chemours Company (CC)

NYSE • Basic Materials

$12.81

-$0.21 (-1.7%)

Market open

Last close at October 23, 2026 at 20:00 UTC

Open$12.99

Previous Close$12.81

Day Range$12.58 - $13.08

Avg. Volume (3M)2.2M

Market Cap$1.9B

52 Week Range

$10.44$28.67

Next EarningsIn 8 daysNov 2, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$1.5B100%

Gross Profitminus cost of goods$286M18%

In plain terms: out of every $100 in revenue, The Chemours Company currently loses $17.

Fundamentals & Financials

Revenue (TTM)

$5.7B

Net Income (TTM)

-$304M

EPS (TTM)

-$2

ROA (TTM)

-4.25%

Current Ratio

1.66

Dividend Yield

0.84%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+26.1%Q3 2025$0.58

-16.7%Q4 2025$0.2

-43.6%Q1 2026$0.05

+200.0%Q2 2026$0.05

-14.1%Q3 2026$0.42

Nov 2

in 8 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Miss -14.1%

The Chemours Company's adjusted EPS missed consensus and revenue also came in below estimates, based on preliminary results for the second fiscal quarter of 2026 reported on Aug. 4, with adjusted EPS of $0.42 missing the $0.50 estimate by -15.4% and down 27.6% from $0.58 a year earlier, while revenue of about $1.59 billion missed the $1.65 billion consensus by -3.8% and slipped 1.5% from a year ago. Gross profit came to about $286 million, with gross margin near 18%, while operating cash flow was about $158 million and the company paid about $13 million in dividends. Consensus for the next period calls for EPS of $0.49 on revenue of $1.59 billion.

Next report — what to expect

The Chemours Company (CC) reports on November 5, 2026. Wall Street expects EPS of $0.273 on revenue of $1.53 billion. For trailing context, revenue declined -1.5% year over year last quarter. Chemours has beaten EPS in 4 of its 8 most recent quarters, so watch for margin and volume commentary.

View full earnings history

About The Chemours Company

The Chemours Company (NYSE: CC) makes specialty chemicals and materials for cooling, pigment, and performance-material applications. In this chemicals business, Chemours generates $5.8 billion of revenue in FY2025 through three segments that span refrigerants and thermal management solutions, titanium dioxide pigment, and a broader advanced materials portfolio.

Name

The Chemours Company

CEO

Denise Dignam

Website

www.chemours.com

Industry

Basic Materials

Year Founded

2014

Employees

5,700

Today's Snapshot

AI-generated

The day ended with CC 1.7% lower at 12.81. Shareholders filed a securities-fraud class action against Chemours. Earnings are due from CC on 2 November.

Trading Volume

Below 10d avg (2.4M)

1.6M

vs S&P 500 Today

Underperforming Market

-1.17%

Updated: October 23, 2026 at 20:26 UTC

CC Headlines

New York sues over PFAS ‘forever chemicals’

July 9, 2026

3 min read

Chemours settles PFAS case for about $450 million

June 24, 2026

4 min read

View All News

Technical Indicators

0 Buy3 Neutral5 Sell

At $12.81, CC shows a pronounced bearish structure with the security trading well below its short-, medium- and long-term moving averages and ADX in the mid-40s signaling a strong downtrend. Momentum readings are weak—RSI and CCI undercut neutral levels—and MACD is non-supportive, while OBV points to selling pressure and volatility is moderate. The combination of strong trend, weak momentum and below-average price placement underpins the strong-sell assessment. Technical takeaway: clear technical sell bias with strong trend confirmation.

All signals